argenx SE reported $44M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
AstraZeneca USD 80M 7M Jun/2026
Genmab DKK 14M 11M Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Qiagen NV USD 10.56M 9.44M Mar/2026